Efficacy of primary hepatitis B immunization in children with acute lymphoblastic leukemia.
dc.contributor.author | Baytan, Birol | en_US |
dc.contributor.author | Gunes, Adalet Meral | en_US |
dc.contributor.author | Gunay, Unsal | en_US |
dc.date.accessioned | 2008-04-03 | en_US |
dc.date.accessioned | 2009-05-27T05:51:24Z | |
dc.date.available | 2008-04-03 | en_US |
dc.date.available | 2009-05-27T05:51:24Z | |
dc.date.issued | 2008-04-03 | en_US |
dc.description.abstract | BACKGROUND: Children with acute lymphoblastic leukemia (ALL) carry a high risk of hepatitis B virus (HIV) infection. The present study was conducted to see if prior routine hepatitis B vaccine received as a part of national immunization program could prevent HBV infection in these children. METHODOLOGY: Ninety-six children with ALL were screened for HBV. Children were divided into three groups according to their initial HBV serology; previously vaccinated children (Group I) (n=34) previously unvaccinated and seronegative children (Group II) (n=56),and unvaccinated but HBsAg negative and anti-HBs positive children (group III) (n=6). Sixty-seven of 96 (69.7%) children received vaccination. The schedule was initiated during the third month of maintenance therapy and each course consisted of three doses given at one month interval. RESULTS: Anti-HBs seroconversion following the first course of three doses of hepatitis B vaccination in group I, II and III was 57%, 33% and 100%, respectively. It increased to 97% in Group I, 62.5% in Group II, 100% in Group III. HBsAg positivity was found in 11 children (11.5%) and all of them developed chronic hepatitis B. Ten of them were in Group II whereas only one child was in Group I (P<0.04). CONCLUSION: This data reveals that routine HBV vaccination within the national immunization program plays an important role in decreasing subsequent hepatitis B infection in children with ALL. | en_US |
dc.description.affiliation | Department of Pediatric Hematology, Uludag University, Medical Faculty, bursa, Turkey. baytanbirol@yahoo.com | en_US |
dc.identifier.citation | Baytan B, Gunes AM, Gunay U. Efficacy of primary hepatitis B immunization in children with acute lymphoblastic leukemia. Indian Pediatrics. 2008 Apr; 45(4): 265-70 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/13549 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianpediatrics.net | en_US |
dc.subject.mesh | Age Factors | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child Welfare | en_US |
dc.subject.mesh | Disease Progression | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Health Status | en_US |
dc.subject.mesh | Hepatitis B --immunology | en_US |
dc.subject.mesh | Hepatitis B Antibodies | en_US |
dc.subject.mesh | Hepatitis B Vaccines | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Precursor Cell Lymphoblastic Leukemia-Lymphoma --physiopathology | en_US |
dc.subject.mesh | Remission Induction | en_US |
dc.subject.mesh | Risk Factors | en_US |
dc.title | Efficacy of primary hepatitis B immunization in children with acute lymphoblastic leukemia. | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |
Files
License bundle
1 - 1 of 1